IrsiCaixa
If you are the contact person for this centre and you wish to make any changes, please contact us.
SMC participants
Head of the Infectious Diseases Service at the Germans Trias i Pujol Hospital and senior researcher at the AIDS Research Institute (IrsiCaixa).
Contents related to this centre
A study published in the New England Journal of Medicine has analysed the effectiveness of the antiviral drug Paxlovid after implantation of the omicron variant. The relative risk of severe disease decreased markedly in patients over 65 years of age, both vaccinated and unvaccinated. No differences were found in those under 65 years of age.